AR035990A1 - Compuestos intermediarios y metodo para preparar cis-1-{2-[4-(6-metoxi-2-fenil-1,2,3,4-tetrahidronaftalen-1-il)fenoxi]etil}pirrolidina - Google Patents
Compuestos intermediarios y metodo para preparar cis-1-{2-[4-(6-metoxi-2-fenil-1,2,3,4-tetrahidronaftalen-1-il)fenoxi]etil}pirrolidinaInfo
- Publication number
- AR035990A1 AR035990A1 ARP000102511A ARP000102511A AR035990A1 AR 035990 A1 AR035990 A1 AR 035990A1 AR P000102511 A ARP000102511 A AR P000102511A AR P000102511 A ARP000102511 A AR P000102511A AR 035990 A1 AR035990 A1 AR 035990A1
- Authority
- AR
- Argentina
- Prior art keywords
- phenyl
- methoxy
- benzyloxy
- ethyl
- bromo
- Prior art date
Links
- RWRDLPDLKQPQOW-UHFFFAOYSA-N tetrahydropyrrole Natural products C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 title abstract 2
- KHUXNRRPPZOJPT-UHFFFAOYSA-N phenoxy radical Chemical compound O=C1C=C[CH]C=C1 KHUXNRRPPZOJPT-UHFFFAOYSA-N 0.000 title 1
- GXAWUBYOPVAHKZ-UHFFFAOYSA-N 7-methoxy-3-phenyl-4-(4-phenylmethoxyphenyl)-1,2-dihydronaphthalene Chemical compound C1CC2=CC(OC)=CC=C2C(C=2C=CC(OCC=3C=CC=CC=3)=CC=2)=C1C1=CC=CC=C1 GXAWUBYOPVAHKZ-UHFFFAOYSA-N 0.000 abstract 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 abstract 3
- CZOYXKZXMKSRQD-UHFFFAOYSA-N 2-[2-(2-bromo-5-methoxyphenyl)ethyl]-2-phenyl-1,3-dioxolane Chemical compound COC1=CC=C(Br)C(CCC2(OCCO2)C=2C=CC=CC=2)=C1 CZOYXKZXMKSRQD-UHFFFAOYSA-N 0.000 abstract 2
- YMAFPDBITYFGPO-UHFFFAOYSA-N 3-(2-bromo-5-methoxyphenyl)-1-phenylpropan-1-one Chemical compound COC1=CC=C(Br)C(CCC(=O)C=2C=CC=CC=2)=C1 YMAFPDBITYFGPO-UHFFFAOYSA-N 0.000 abstract 2
- WQRDHSBFQYMBGZ-UHFFFAOYSA-N 3-[5-methoxy-2-(4-phenylmethoxybenzoyl)phenyl]-1-phenylpropan-1-one Chemical compound C=1C=CC=CC=1C(=O)CCC1=CC(OC)=CC=C1C(=O)C(C=C1)=CC=C1OCC1=CC=CC=C1 WQRDHSBFQYMBGZ-UHFFFAOYSA-N 0.000 abstract 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 abstract 2
- SIMZFBKLJVJWHL-UHFFFAOYSA-N [4-methoxy-2-[2-(2-phenyl-1,3-dioxolan-2-yl)ethyl]phenyl]-(4-phenylmethoxyphenyl)methanone Chemical compound O1CCOC1(C=1C=CC=CC=1)CCC1=CC(OC)=CC=C1C(=O)C(C=C1)=CC=C1OCC1=CC=CC=C1 SIMZFBKLJVJWHL-UHFFFAOYSA-N 0.000 abstract 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 abstract 2
- NAPIZYZVKMASNP-UHFFFAOYSA-N 1-[2-[4-(6-methoxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy]ethyl]pyrrolidine Chemical compound C1CC2=CC(OC)=CC=C2C(C=2C=CC(OCCN3CCCC3)=CC=2)C1C1=CC=CC=C1 NAPIZYZVKMASNP-UHFFFAOYSA-N 0.000 abstract 1
- MURVUTUZSUEIGI-UHFFFAOYSA-N 1-bromo-2-(bromomethyl)-4-methoxybenzene Chemical compound COC1=CC=C(Br)C(CBr)=C1 MURVUTUZSUEIGI-UHFFFAOYSA-N 0.000 abstract 1
- BLZNSXFQRKVFRP-UHFFFAOYSA-N 1-bromo-4-methoxy-2-methylbenzene Chemical compound COC1=CC=C(Br)C(C)=C1 BLZNSXFQRKVFRP-UHFFFAOYSA-N 0.000 abstract 1
- UDAOJHAASAWVIQ-UHFFFAOYSA-N 4-phenylmethoxybenzonitrile Chemical compound C1=CC(C#N)=CC=C1OCC1=CC=CC=C1 UDAOJHAASAWVIQ-UHFFFAOYSA-N 0.000 abstract 1
- TVZPLCNGKSPOJA-UHFFFAOYSA-N copper zinc Chemical compound [Cu].[Zn] TVZPLCNGKSPOJA-UHFFFAOYSA-N 0.000 abstract 1
- XBRDBODLCHKXHI-UHFFFAOYSA-N epolamine Chemical compound OCCN1CCCC1 XBRDBODLCHKXHI-UHFFFAOYSA-N 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 abstract 1
- YONPGGFAJWQGJC-UHFFFAOYSA-K titanium(iii) chloride Chemical compound Cl[Ti](Cl)Cl YONPGGFAJWQGJC-UHFFFAOYSA-K 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/215—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring having unsaturation outside the six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
- C07C45/48—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation involving decarboxylation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
- C07C45/57—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom
- C07C45/59—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom in five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
- C07D317/22—Radicals substituted by singly bound oxygen or sulfur atoms etherified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/26—Radicals substituted by doubly bound oxygen or sulfur atoms or by two such atoms singly bound to the same carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13557899P | 1999-05-24 | 1999-05-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR035990A1 true AR035990A1 (es) | 2004-08-04 |
Family
ID=22468706
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP000102511A AR035990A1 (es) | 1999-05-24 | 2000-05-23 | Compuestos intermediarios y metodo para preparar cis-1-{2-[4-(6-metoxi-2-fenil-1,2,3,4-tetrahidronaftalen-1-il)fenoxi]etil}pirrolidina |
Country Status (24)
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| YU26700A (sh) * | 1999-05-24 | 2002-06-19 | Pfizer Products Inc. | Postupak za cis-1-(2-(4-(6-metoksi-2-fenil-1,2,3,4- tetrahidronaftalen-1-il)fenoksi)etil)pirolidin |
| HUP0500025A3 (en) * | 2002-03-28 | 2005-10-28 | Pfizer Prod Inc | Purified lasofoxifene and a method for purification of racemic lasofoxifene by recrystallization |
| PA8576201A1 (es) * | 2002-07-10 | 2004-05-26 | Pfizer Prod Inc | Composicion farmaceutica que tiene una distribucion y potencia uniforme de farmaco |
| JP5212931B2 (ja) * | 2006-01-26 | 2013-06-19 | 学校法人東京理科大学 | ラソフォキシフェン及びその類縁体の製造方法 |
| CZ2007373A3 (cs) * | 2007-05-29 | 2008-12-10 | Zentiva, A. S | Zpusob prípravy lasofoxifenu |
| CN102424661A (zh) * | 2011-10-21 | 2012-04-25 | 南开大学 | 一种偶氮类色素半抗原与人工抗原的合成方法 |
| CN103113323B (zh) * | 2013-02-05 | 2015-11-11 | 南京华威医药科技开发有限公司 | 酒石酸拉索昔芬中间体的制备方法 |
| JP6892151B2 (ja) | 2016-10-11 | 2021-06-23 | デューク ユニバーシティ | Ｅｒ＋乳がんのラソフォキシフェン処置 |
| WO2019199891A1 (en) | 2018-04-10 | 2019-10-17 | Duke University | Lasofoxifene treatment of breast cancer |
| GB202116903D0 (en) | 2021-11-18 | 2022-01-05 | Sermonix Pharmaceuticals Inc | Lasofoxifene treatment of aromatase-resistant er+ cancer |
| WO2025043004A1 (en) | 2023-08-21 | 2025-02-27 | Duke University | Treatment of solid cancer with lasofoxifene |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3274213A (en) * | 1961-09-05 | 1966-09-20 | Upjohn Co | Alkoxy-substituted 2-phenyl-1-(tertiary-aminoalkoxy)phenyl-3, 4-dihydronaphthalenes |
| US3234090A (en) | 1962-09-10 | 1966-02-08 | Ciba Geigy Corp | Pharmaceutical compositions comprising saturated basic ethers |
| US3522319A (en) | 1964-01-23 | 1970-07-28 | Ciba Geigy Corp | Phenol substituted tetrahydronaphthalenes useful as estrogenics |
| FR2678938B1 (fr) * | 1991-07-10 | 1993-10-08 | Rhone Poulenc Rorer Sa | Derives de pyrrolidine, leur preparation et les medicaments les contenant. |
| US5552412A (en) * | 1995-01-09 | 1996-09-03 | Pfizer Inc | 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis |
| US5552241A (en) * | 1995-05-10 | 1996-09-03 | Electrochemical Systems, Inc. | Low temperature molten salt compositions containing fluoropyrazolium salts |
| UA51676C2 (uk) * | 1995-11-02 | 2002-12-16 | Пфайзер Інк. | (-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція |
| AU717012B2 (en) * | 1995-11-17 | 2000-03-16 | Merck & Co., Inc. | Novel substituted aryl compounds useful as modulators of acetylcholine receptors |
| US6509356B1 (en) * | 1997-08-07 | 2003-01-21 | Eli Lilly And Company | 1-(4-(Substituted alkoxy)benzyl)naphthalene compounds having estrogen inhibitory activity |
| YU26700A (sh) * | 1999-05-24 | 2002-06-19 | Pfizer Products Inc. | Postupak za cis-1-(2-(4-(6-metoksi-2-fenil-1,2,3,4- tetrahidronaftalen-1-il)fenoksi)etil)pirolidin |
-
2000
- 2000-05-08 YU YU26700A patent/YU26700A/sh unknown
- 2000-05-18 IL IL13623100A patent/IL136231A/xx not_active IP Right Cessation
- 2000-05-18 CN CN00108576A patent/CN1280128A/zh active Pending
- 2000-05-18 CN CNB200310119668XA patent/CN1271030C/zh not_active Expired - Fee Related
- 2000-05-18 CN CNB2003101196675A patent/CN1226265C/zh not_active Expired - Fee Related
- 2000-05-19 PT PT00304247T patent/PT1055658E/pt unknown
- 2000-05-19 DK DK00304247T patent/DK1055658T3/da active
- 2000-05-19 AT AT00304247T patent/ATE234269T1/de not_active IP Right Cessation
- 2000-05-19 DE DE60001599T patent/DE60001599T2/de not_active Expired - Lifetime
- 2000-05-19 US US09/575,310 patent/US6232476B1/en not_active Expired - Lifetime
- 2000-05-19 CA CA002308922A patent/CA2308922C/en not_active Expired - Lifetime
- 2000-05-19 EP EP00304247A patent/EP1055658B1/en not_active Expired - Lifetime
- 2000-05-19 TW TW089109704A patent/TWI231295B/zh not_active IP Right Cessation
- 2000-05-19 ES ES00304247T patent/ES2191597T3/es not_active Expired - Lifetime
- 2000-05-22 IN IN466MU2000 patent/IN188849B/en unknown
- 2000-05-22 ID IDP20000430A patent/ID26146A/id unknown
- 2000-05-22 ZA ZA200002514A patent/ZA200002514B/xx unknown
- 2000-05-23 BR BRPI0001813-9A patent/BR0001813B1/pt not_active IP Right Cessation
- 2000-05-23 HU HU0001988A patent/HUP0001988A3/hu unknown
- 2000-05-23 AR ARP000102511A patent/AR035990A1/es active IP Right Grant
- 2000-05-23 KR KR10-2000-0027611A patent/KR100388176B1/ko not_active Expired - Fee Related
- 2000-05-23 TR TR2000/01476A patent/TR200001476A2/xx unknown
- 2000-05-23 RU RU2000112848/04A patent/RU2195445C2/ru not_active IP Right Cessation
- 2000-05-23 AU AU36362/00A patent/AU769690B2/en not_active Ceased
- 2000-05-24 PL PL00340237A patent/PL340237A1/xx not_active IP Right Cessation
- 2000-05-24 JP JP2000152901A patent/JP3296809B2/ja not_active Expired - Fee Related
-
2001
- 2001-02-27 US US09/794,382 patent/US6323345B1/en not_active Expired - Lifetime
- 2001-10-09 US US09/974,309 patent/US6395911B1/en not_active Expired - Lifetime
- 2001-11-28 JP JP2001362058A patent/JP3600206B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR035990A1 (es) | Compuestos intermediarios y metodo para preparar cis-1-{2-[4-(6-metoxi-2-fenil-1,2,3,4-tetrahidronaftalen-1-il)fenoxi]etil}pirrolidina | |
| Potin et al. | New chiral auxiliaries: their use in the asymmetric hydrogenation of. beta.-acetamidocrotonates | |
| CN1353688A (zh) | 由苯甲酸酯衍生的化合物、含有上述化合物的组合物及其用途 | |
| RU2000112848A (ru) | Способ получения цис-1{2-[4-(6-метокси-2-фенил-1,2,3,4-тетрагидронафталин-1-ил)фенокси]этил }пирролидина | |
| CN103242197B (zh) | 一种紫外吸收剂中间体依托立林的制备方法 | |
| JPH08231447A (ja) | 光学活性アルコールの製造方法 | |
| CN1871200A (zh) | 粉未状白色固体光引发剂及其制备 | |
| CA2532458C (en) | Clear photopolymerizable systems for the preparation of high thickness coatings | |
| EA200901615A1 (ru) | Способ получения лазофоксифена | |
| US8163952B2 (en) | RAR receptor agonist ligands and use thereof in human medicine and cosmetics | |
| CN109336925A (zh) | 一种光引发剂2,4,6-三甲基苯甲酰基-二苯基氧化膦的新合成方法 | |
| US20050107629A1 (en) | Method for producing ethyl acrylate | |
| Yamamoto et al. | Chemical synthesis of a very long-chain fatty acid, hexacosanoic acid (C26: 0), and the ceramide containing hexacosanoic acid | |
| US7879907B2 (en) | 3-phenylpropanoic compound activators of receptors of PPAR type and pharmaceutical/cosmetic compositions comprised thereof | |
| CN113336711B (zh) | 氟丙嘧草酯的合成方法 | |
| EP1742608B1 (en) | Biaromatic compounds which activate ppar(gamma) type receptors, their process of preparation and their use in cosmetic or pharmaceutical compositions | |
| NL8003363A (nl) | Werkwijze ter bereiding van optisch actieve aryloxyalkaanzuren en derivaten daarvan. | |
| CA2555051A1 (en) | Process for cis-1-{2-[4-(6-methoxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy]ethyl}pyrrolidine | |
| US6297390B1 (en) | Method for preparing optically active 5-methyl-2-(1-methyl-butyl)-5-propyl-1,3-dioxan | |
| Abe et al. | Electrochemical fluorination of 1-ethylpiperazine and 4-methyl-and/or 4-ethylpiperazinyl substituted carboxylic acid methyl esters | |
| Afraz et al. | Efficient resolution of 2-phenylbutyric acid | |
| US7517907B2 (en) | Pharmaceutical/cosmetic compositions comprising a novel RARbeta receptor-activating ligand | |
| Evans et al. | Diastereoselectivity in α-Benzylation Reactions of Esters of Spiro [bornane-3, 2′-indan]-2-exo-ol | |
| CN120623141A (zh) | 一种苹果酯的制备方法 | |
| WO2005122670A3 (en) | Biomonitored synthesis route for large scale preparation of cardol (bilobol) and 11δ-cardol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |